These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35324534)

  • 1. Ubiquitin-specific protease 1 inhibition sensitizes hepatocellular carcinoma cells to doxorubicin by ubiquitinated proliferating cell nuclear antigen-mediated attenuation of stemness.
    Lu Z; Zhang Z; Yang M; Xiao M
    Anticancer Drugs; 2022 Aug; 33(7):622-631. PubMed ID: 35324534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of ubiquitin-specific protease 1 reveals its importance in hepatocellular carcinoma.
    Zhao Y; Xue C; Xie Z; Ouyang X; Li L
    Cell Prolif; 2020 Oct; 53(10):e12908. PubMed ID: 32951278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells.
    Liao Y; Shao Z; Liu Y; Xia X; Deng Y; Yu C; Sun W; Kong W; He X; Liu F; Guo Z; Chen G; Tang D; Gan H; Liu J; Huang H
    J Exp Clin Cancer Res; 2021 Jun; 40(1):201. PubMed ID: 34154657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin-specific protease 1 acts as an oncogene and promotes lenvatinib efficacy in hepatocellular carcinoma by stabilizing c-kit.
    Chen Z; Ma Y; Guo Z; Song D; Chen Z; Sun M
    Ann Hepatol; 2022; 27(2):100669. PubMed ID: 35045360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of USP1 induces apoptosis via ID1/AKT pathway in B-cell acute lymphoblastic leukemia cells.
    Kuang X; Xiong J; Lu T; Wang W; Zhang Z; Wang J
    Int J Med Sci; 2021; 18(1):245-255. PubMed ID: 33390793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of USP1 activates ER stress through Ubi-protein aggregation to induce autophagy and apoptosis in HCC.
    Wang L; Hu T; Shen Z; Zheng Y; Geng Q; Li L; Sha B; Li M; Sun Y; Guo Y; Xue W; Xuan D; Chen P; Zhao J
    Cell Death Dis; 2022 Nov; 13(11):951. PubMed ID: 36357365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin-induced senescence promotes stemness and tumorigenicity in EpCAM-/CD133- nonstem cell population in hepatocellular carcinoma cell line, HuH-7.
    Karabicici M; Alptekin S; Fırtına Karagonlar Z; Erdal E
    Mol Oncol; 2021 Aug; 15(8):2185-2202. PubMed ID: 33524223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of USP1 enhances anticancer drugs-induced cancer cell death through downregulation of survivin and miR-216a-5p-mediated upregulation of DR5.
    Woo SM; Kim S; Seo SU; Kim S; Park JW; Kim G; Choi YR; Hur K; Kwon TK
    Cell Death Dis; 2022 Sep; 13(9):821. PubMed ID: 36153316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical exercise suppresses hepatocellular carcinoma progression by alleviating hypoxia and attenuating cancer stemness through the Akt/GSK-3β/β-catenin pathway.
    Xiao CL; Zhong ZP; Lü C; Guo BJ; Chen JJ; Zhao T; Yin ZF; Li B
    J Integr Med; 2023 Mar; 21(2):184-193. PubMed ID: 36781361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells.
    Das DS; Das A; Ray A; Song Y; Samur MK; Munshi NC; Chauhan D; Anderson KC
    Clin Cancer Res; 2017 Aug; 23(15):4280-4289. PubMed ID: 28270494
    [No Abstract]   [Full Text] [Related]  

  • 11. Knockdown of BAP31 Overcomes Hepatocellular Carcinoma Doxorubicin Resistance through Downregulation of Survivin.
    Liu J; Zhang Q; Wang C; Yang J; Yang S; Wang T; Wang B
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low‑intensity ultrasound enhances the antitumor effects of doxorubicin on hepatocellular carcinoma cells through the ROS‑miR‑21‑PTEN axis.
    Xia C; Zeng H; Zheng Y
    Mol Med Rep; 2020 Mar; 21(3):989-998. PubMed ID: 32016465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Doxorubicin-Loaded Omega-3 Unsaturated Fatty Acids Nanoparticles in Reversing Hepatocellular Carcinoma Multidrug Resistance.
    Wang C; Wei X; Shao G
    Med Sci Monit; 2021 Feb; 27():e927727. PubMed ID: 33524008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2.
    Tu C; Chen W; Wang S; Tan W; Guo J; Shao C; Wang W
    J Cell Mol Med; 2019 Nov; 23(11):7190-7199. PubMed ID: 30801960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways.
    Zheng T; Wang J; Song X; Meng X; Pan S; Jiang H; Liu L
    J Cancer Res Clin Oncol; 2010 Oct; 136(10):1597-604. PubMed ID: 20174822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitinated PCNA Drives USP1 Synthetic Lethality in Cancer.
    Simoneau A; Engel JL; Bandi M; Lazarides K; Liu S; Meier SR; Choi AH; Zhang H; Shen B; Martires L; Gotur D; Pham TV; Li F; Gu L; Gong S; Zhang M; Wilker E; Pan X; Whittington DA; Throner S; Maxwell JP; Chen Y; Yu Y; Huang A; Andersen JN; Feng T
    Mol Cancer Ther; 2023 Feb; 22(2):215-226. PubMed ID: 36228090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma.
    Xu F; Liao JZ; Xiang GY; Zhao PX; Ye F; Zhao Q; He XX
    Cancer Med; 2017 Mar; 6(3):651-661. PubMed ID: 28135055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of the miR-325-3p/DPAGT1 axis supports HBV-positive HCC chemoresistance.
    Li R; Xu T; Wang H; Wu N; Liu F; Jia X; Mi J; Lv J; Gao H
    Biochem Biophys Res Commun; 2019 Nov; 519(2):358-365. PubMed ID: 31519321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.